Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Seeger

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Human Vaccines & Immunotherapeutics|June 17, 2022
Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing studyKandace L Amend, Bruce Turnbull, Li Zhou, et al.
Pharmacoepidemiology and Drug Safety|February 7, 2015
Accuracy of ICD-9-CM coding to identify small for gestational age newbornsKelesitse Phiri, Sonia Hernandez-Diaz, Lawrence C Tsen, et al.
Journal of Clinical Lipidology|September 27, 2012
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemiaJennifer B Christian, Bhakti Arondekar, Erin K Buysman, et al.
Vaccine|November 24, 2022
Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United StatesJohn D Seeger, Kandace L Amend, Bruce R Turnbull, et al.
Cephalalgia : an International Journal of Headache|June 15, 2019
Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort studyVeena Hoffman, Fei Xue, Stephen M Ezzy, et al.
Contraception|October 22, 2008
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptivesJeanne Loughlin, John D Seeger, P Mona Eng, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 5, 2010
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort studyJeanne Loughlin, Sherry Quinn, Elena Rivero, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2014
A cross-national comparison of 17 countries' insulin glargine drug labelsJennifer M Polinski, Aaron S Kesselheim, John D Seeger, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Journal of the American College of Cardiology|April 2, 2013
Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiariesChih-Ying Chen, Lynne Warner Stevenson, Garrick C Stewart, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Human Vaccines & Immunotherapeutics|June 17, 2022
Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing studyKandace L Amend, Bruce Turnbull, Li Zhou, et al.
Pharmacoepidemiology and Drug Safety|February 7, 2015
Accuracy of ICD-9-CM coding to identify small for gestational age newbornsKelesitse Phiri, Sonia Hernandez-Diaz, Lawrence C Tsen, et al.
Journal of Clinical Lipidology|September 27, 2012
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemiaJennifer B Christian, Bhakti Arondekar, Erin K Buysman, et al.
Vaccine|November 24, 2022
Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United StatesJohn D Seeger, Kandace L Amend, Bruce R Turnbull, et al.
Cephalalgia : an International Journal of Headache|June 15, 2019
Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort studyVeena Hoffman, Fei Xue, Stephen M Ezzy, et al.
Contraception|October 22, 2008
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptivesJeanne Loughlin, John D Seeger, P Mona Eng, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 5, 2010
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort studyJeanne Loughlin, Sherry Quinn, Elena Rivero, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2014
A cross-national comparison of 17 countries' insulin glargine drug labelsJennifer M Polinski, Aaron S Kesselheim, John D Seeger, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Journal of the American College of Cardiology|April 2, 2013
Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiariesChih-Ying Chen, Lynne Warner Stevenson, Garrick C Stewart, et al.
Pageof 14